Comms or nah? CLOT SHOT?
Addenbrooke's Hospital: Baby who died was not given routine vitamin
A coroner has found there was "gross failure in medical care amounting to neglect" in the death of a baby who was not given a routine vitamin after birth.
William Moris-Patto was born at Addenbrooke's Hospital in Cambridge in July 2020 but died seven weeks later having suffered a brain bleed.
Coroner Lorna Skinner KC said he would not have died had he been given vitamin K, needed for blood clotting.
The hospital trust has apologised.
The inquest, held in Huntingdon, heard William was born premature at 34 weeks, on 27 July, and his mother had specifically asked about whether William had received a vitamin K shot.
"So far as she can recall, when she asked if William had had all the necessary postnatal checks and care, a female member of the… staff said 'yes, everything's been done'," Ms Skinner said.
William stayed in hospital for two weeks, when he was discharged with a nasogastric tube, but became unwell overnight on 11 September and had been sick.
His parents, from Chatteris, rang the NHS 111 service, which in turn led to an ambulance being called and William was taken to Addenbrooke's.
Ms Skinner said surgery was performed on William but clinicians "believed the damage to his brain was too great and he would never recover", and he died on 17 September.
The coroner said she had heard from his mother Naomi Moris that William's death was "nothing short of devastating".
Moar
https://www.yahoo.com/news/addenbrookes-hospital-baby-died-not-150436901.html
Vitamin K given at Birth.What, if anything, does this have in connection to the Q drop about DNA, and WHO put it there?
Newborn Vitamin K Prophylaxis: A Historical Perspective to Understand Modern Barriers to Uptake
Since its initial discovery almost a century ago, vitamin K has been labeled as both lifesaving and malignancy causing. This has led to debate of not only its use in general but also regarding its appropriate dose and route. In this article, we review through a historical lens the past 90 years of newborn vitamin K from its discovery through to its modern use of preventing vitamin K deficiency bleeding (VKDB). Although researchers in surveillance studies have shown considerable reductions in VKDB following intramuscular vitamin K prophylaxis, ongoing barriers to the universal uptake of vitamin K prophylaxis remain. Reviewing the history of newborn vitamin K provides an opportunity for a greater understanding of the current barriers to uptake that we face. Although at times difficult, improving this understanding may allow us to address contentious issues related to parental and health professional beliefs and values as well as improve overall communication. The ultimate goal is to improve and maintain the uptake of vitamin K to prevent VKDB in newborns.
The history of vitamin K dates back to 1929, when the Danish biochemist Henrik Dam (1895–1976) observed that chicks fed fat- and cholesterol-free diets developed subcutaneous and muscular hemorrhages.2 He subsequently proposed that this fat-soluble active compound was different from the other known fat-soluble vitamins A, D, and E, and that this new anti-hemorrhagic factor should be named vitamin K (in reference to koagulation from the German and Scandinavian languages).3
Subsequently, in the early 1940s, Edward Doisy confirmed the structure and identity of the 2 naturally occurring forms of vitamin K, phylloquinone (vitamin K1) and menaquinone (vitamin K2; Fig 1).4,5 For these discoveries, Dam2 and Doisy were awarded the Nobel Prize in Physiology or Medicine (1943).3
After the Swedish experiments of the 1940s, it was not until 1961 that the American Academy of Pediatrics first recommended IM vitamin K prophylaxis immediately after birth for all newborns.19 Now, nearly all developed countries have implemented vitamin K prophylaxis programs, usually recommending 1 mg of IM vitamin K (Konakion MM) at birth or 0.5 mg in preterm infants. If parents decline an IM injection, an alternative option is 2 mg of Konakion MM orally at birth and again at 3 to 5 days, followed by an additional dose at 4 to 6 weeks of age.20 This option is likely less effective than IM21 and certainly more complicated. Because of this efficacy issue (as well as availability), the American Academy of Pediatrics, in contrast to some countries, still does not have a policy statement on the use of oral prophylaxis.22
full article
https://publications.aap.org/hospitalpediatrics/article/9/1/55/26668/Newborn-Vitamin-K-Prophylaxis-A-Historical?autologincheck=redirected